CD248 and non-small cell lung carcinoma: To elucidate whether the CD248‐expressing CAFs mediates cisplatin resistance in NSCLC, we treated NSCLC cell lines with CM from CAFs, CAFs‐sh‐CON or CD248‐sh‐CD248, prior to exposure to varying concentrations of cisplatin.